Madrigal Pharmaceuticals, Inc. MDGL Net Investment in Lease
Net Investment in Lease at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s net investment in lease.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s net investment in lease?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported net investment in lease of $6.2M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s net investment in lease changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s net investment in lease increased by 194.0% year-over-year, from $2.11M to $6.2M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s net investment in lease?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s net investment in lease has grown at a 44.5% compound annual growth rate (CAGR), from $785K to $4.94M.